| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: Use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents
|
Peric, Mihaela
|
|
2003
|
25 |
1 |
p. 169-177
9 p.
|
artikel
|
| 2 |
Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: A multicenter, randomized, double-blind, placebo-controlled trial
|
Sittl, Reinhard
|
|
2003
|
25 |
1 |
p. 150-168
19 p.
|
artikel
|
| 3 |
An economic assessment of inhaled formoterol dry powder versus ipratropium bromide pressurized metered dose inhaler in the treatment of chronic obstructive pulmonary disease
|
Hogan, Thomas J
|
|
2003
|
25 |
1 |
p. 285-297
13 p.
|
artikel
|
| 4 |
An examination of the results of the EVIDENCE, INCOMIN, and phase III studies of interferon beta products in the treatment of multiple sclerosis
|
Vartanian, Timothy
|
|
2003
|
25 |
1 |
p. 105-118
14 p.
|
artikel
|
| 5 |
An open-label, nonrandomized, single-center, prospective extension, clinical trial of booster dose schedules to assess the safety profile and immunogenicity of recombinant outer-surface protein A (OspA) Lyme disease vaccine
|
Schoen, Robert T
|
|
2003
|
25 |
1 |
p. 210-224
15 p.
|
artikel
|
| 6 |
An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations
|
Weidmann, Eric
|
|
2003
|
25 |
1 |
p. 235-246
12 p.
|
artikel
|
| 7 |
Approaches to pharmacy benefit management and the impact of consumer cost sharing
|
Olson, Bridget M
|
|
2003
|
25 |
1 |
p. 250-272
23 p.
|
artikel
|
| 8 |
A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals
|
Vogel, Ronald J
|
|
2003
|
25 |
1 |
p. 309-329
21 p.
|
artikel
|
| 9 |
A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: The treat-to-target (3T) study
|
Olsson, Anders G
|
|
2003
|
25 |
1 |
p. 119-138
20 p.
|
artikel
|
| 10 |
Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: A multicenter, double-blind, randomized, placebo-controlled trial
|
De Jesus Moreno Moreno, Maria
|
|
2003
|
25 |
1 |
p. 178-193
16 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
2003
|
25 |
1 |
p. IFC-
1 p.
|
artikel
|
| 12 |
Effect of amlodipine on systolic blood pressure
|
Levine, Cindy B
|
|
2003
|
25 |
1 |
p. 35-57
23 p.
|
artikel
|
| 13 |
Effect of daily and intermittent use of ibandronate on bone mass and bone turnover in postmenopausal osteoporosis: A review of three phase II studies
|
Schimmer, Ralph C
|
|
2003
|
25 |
1 |
p. 19-34
16 p.
|
artikel
|
| 14 |
Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: A randomized, placebo-controlled study
|
Luis Bautista, J
|
|
2003
|
25 |
1 |
p. 194-209
16 p.
|
artikel
|
| 15 |
Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials
|
Backonja, Miroslav
|
|
2003
|
25 |
1 |
p. 81-104
24 p.
|
artikel
|
| 16 |
Open-label, sequential comparison of eptifibatide with abciximab for patients undergoing percutaneous coronary intervention
|
Schweiger, Marc J
|
|
2003
|
25 |
1 |
p. 225-234
10 p.
|
artikel
|
| 17 |
Physician gender and changes in drug prescribing after the implementation of reference pricing in British Columbia
|
Duetz, Margreet S
|
|
2003
|
25 |
1 |
p. 273-284
12 p.
|
artikel
|
| 18 |
Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: Results of an open-label study
|
Campanati, Anna
|
|
2003
|
25 |
1 |
p. 298-308
11 p.
|
artikel
|
| 19 |
The brief history and uncertain future of prescription drug benefits
|
Lyles, Alan
|
|
2003
|
25 |
1 |
p. 248-249
2 p.
|
artikel
|
| 20 |
The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents
|
Armstrong, Edward P
|
|
2003
|
25 |
1 |
p. 1-18
18 p.
|
artikel
|
| 21 |
The prevalence of cardiorenal risk factors in patients prescribed nonsteroidal anti-inflammatory drugs: Data from managed care
|
Harley, Carolyn
|
|
2003
|
25 |
1 |
p. 139-149
11 p.
|
artikel
|
| 22 |
Weight management and current options in pharmacotherapy: Orlistat and sibutramine
|
Leung, Wilson Y.S
|
|
2003
|
25 |
1 |
p. 58-80
23 p.
|
artikel
|
Tijdschrift beschrijving